Dorian therapeutics
AcquiredNew therapeutics to rejuvenate tissue and treat age-related diseases
San Carlos, United States · Founded 2018 · $4.2M raised
- Headquarters
- San Carlos, California
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- doriantherapeutics.com
- Total Funding
- $4.2M
- Last Round
- GrantMay 2025
- Rounds
- 6
- Acquired by
- Altos LabsMay 2025
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Dorian Therapeutics is a pre-clinical biotechnology company based in San Carlos, California, focused on developing a new class of therapeutics called senoblockers that can rejuvenate cells and tissues to counteract aging in degenerative diseases and during cellular therapy. Founded in 2018 by Stanford alumni Maddalena Adorno and Benedetta di Robilant, the company is based on proprietary patented technology for identifying compounds that block senescence-related pathways. Dorian was a Y Combinator Summer 2018 company and is backed by leading venture firms including Longevity Capital, Blumberg Capital, and Pacific 8 Ventures. The company was acquired by Altos Labs in 2025.
Summary
Dorian therapeutics is a Biotech company based in San Carlos, United States, founded in 2018. It has raised $4.2M in total across 6 rounds, most recently a Grant round in May 2025. Investors include Y Combinator, Stanford University and Vento.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
May 2025
Sign up to see all 8 events
Funding: Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/doriantx"><img src="https://indexed.vc/api/badge/company/doriantx" alt="Dorian therapeutics on Indexed.vc" width="260" height="76" /></a>